Indolenter Tumor

Marginal Zone B-Cell lymphoma (MALToma) Indolent B-Cell Non-Hodgkin’s Lymphoma

1. Indolent B cell Lymphomas presented by Dr Allanah Kilfoyle
2. ROXANE: impact of 21-gene assay on treatment for early breast cancer
3. Len and obinutuzumab in relapsed indolent lymphoma: improving R2?

Cancer Research: FDA approves CAR T-cell therapy for indolent follicular lymphoma

• Challenges of MRI in prostate cancer
• Orthopedic Oncology Course - Radiology of Musculoskeletal Tumors - Lecture 2
• New approach to prostate cancer screening
• Ask the Expert: What Role Do Risk Stratification Tools Play in Focal Therapy?
• Dr. O'Shaughnessy on the Future of Breast Cancer Treatment

What was new in indolent NHL at ASCO and EHA?

• IMT: Inflammatory Myofibroblastic Tumor...Explained by a Soft Tissue Pathologist
• Clinical trials: Effect of Vitamin D on Survival in NHL Patients Treated with Rituximab
• Complexities in Diagnosing Neuroendocrine Tumors

Primary Tumor Surgery

• UCLA Kidney Cancer Program: Tumor Profiling | UCLA Urology
• ‘Differential diagnosis of renal tumours’ delivered by Dr. Hersh Chandarana
• Non-Hodgkin's lymphoma (NHL) B-cell and T-cell | Aggressive and Indolent
• Does it have the hall marks of cancer?
• Search options
• YouTube TV
• YouTube Music

YouTube Kids

• Creator Academy